COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,579 Articles (22,415 medRxiv, 8,164 bioRxiv)

Most recent first Previous |  Page 2922: Articles 29211-29220  | Next

Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue
Aguiar, J. A., Tremblay, B. J.-M., Mansfield, M. J., Woody, O., Lobb, B., Banerjee, A., Chandiramohan, A., Tiessen, N., Dvorkin-Gheva, A., Revill, S., Miller, M. S., Carlsten, C., Organ, L., Joseph, C., John, A., Jenkins, G., Mossman, K., Ask, K., Doxey, A. C., Hirota, J. A.
10.1101/2020.04.07.030742 — Posted: 2020-04-09
Tocilizumab treatment in severe COVID-19 patients attenuates the inflammatory storm incited by monocyte centric immune interactions revealed by single-cell analysis
Guo, C., Li, B., Ma, H., Wang, X., Cai, P., Yu, Q., Zhu, L., Jin, L., Jiang, C., Fang, J., Liu, Q., Zong, D., Zhang, W., Lu, Y., Li, K., Gao, X., Fu, B., Liu, L., Ma, X., Weng, J., Wei, H., Jin, T., Lin, J., Qu, K.
10.1101/2020.04.08.029769 — Posted: 2020-04-09 Discussion: Onsite | Offsite
Decoding the lethal effect of SARS-CoV-2 (novel coronavirus) strains from global perspective: molecular pathogenesis and evolutionary divergence
Banerjee, S., Dhar, S., Bhattacharjee, S., Bhattacharjee, P.
10.1101/2020.04.06.027854 — Posted: 2020-04-09 Discussion: Onsite
The aging transcriptome and cellular landscape of the human lung in relation to SARS-CoV-2
Chow, R. D., Chen, S.
10.1101/2020.04.07.030684 — Posted: 2020-04-09 Discussion: Onsite
Reversal of Infected Host Gene Expression Identifies Repurposed Drug Candidates for COVID-19
Xing, J., Shankar, R., Drelich, A., Paithankar, S., Chekalin, E., Dexheimer, T., Rajasekaran, S., Tseng, C.-T. K., Chen, B.
10.1101/2020.04.07.030734 — Posted: 2020-04-09
Immunoglobulin fragment F(ab')2 against RBD potently neutralizes SARS-CoV-2 in vitro
Pan, X., Zhou, P., Fan, T., Wu, Y., Zhang, J., Shi, X., Shang, W., Fang, L., Jiang, X., Shi, J., Sun, Y., Zhao, S., Gong, R., Chen, Z., Xiao, G.
10.1101/2020.04.07.029884 — Posted: 2020-04-09
JAK1 inhibition blocks lethal sterile immune responses:implications for COVID-19 therapy
Tuttle, K., Minter, R., Waugh, K., Araya, P., Ludwig, M., Sempeck, C., Smith, K., Andrysik, Z., Burchill, M., Tamburini, B., Orlicky, D., Sullivan, K. D., Espinosa, J.
10.1101/2020.04.07.024455 — Posted: 2020-04-09
Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus
Temmam, S., Barbarino, A., Maso, D., Behillil, S., Enouf, V., Huon, C., Jaraud, A., Chevallier, L., Backovic, M., Perot, P., Verwaerde, P., Tiret, L., van der Werf, S., Eloit, M.
10.1101/2020.04.07.029090 — Posted: 2020-04-09 Discussion: Onsite | Offsite
The IMPDH inhibitor merimepodib suppresses SARS-CoV-2 replication in vitro.
Bukreyeva, N., Mantlo, E. K., Sattler, R. A., Huang, C., Paessler, S., Zeldis, J.
10.1101/2020.04.07.028589 — Posted: 2020-04-09
Structural and functional analysis of a potent sarbecovirus neutralizing antibody
Corti, D., Pinto, D., Park, Y.-J., Beltramello, M., Walls, A. C., Tortorici, M. A., Bianchi, S., Jaconi, S., Culap, K., Zatta, F., De Marco, A., Peter, A., Guarino, B., Spreafico, R., Cameroni, E., Case, J. B., Chen, R. E., Havenar-Daughton, C., Snell, G., Telenti, A., Virgin, H. W., Lanzavecchia, A., Diamond, M. S., Fink, K., Veesler, D.
10.1101/2020.04.07.023903 — Posted: 2020-04-09 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).